These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Influence of in utero diethylstilbestrol exposure on the prognosis and biologic behavior of vaginal clear-cell adenocarcinoma. Waggoner SE, Mittendorf R, Biney N, Anderson D, Herbst AL. Gynecol Oncol; 1994 Nov; 55(2):238-44. PubMed ID: 7959291 [Abstract] [Full Text] [Related]
29. Epidemiologic aspects and factors related to survival in 384 Registry cases of clear cell adenocarcinoma of the vagina and cervix. Herbst AL, Cole P, Norusis MJ, Welch WR, Scully RE. Am J Obstet Gynecol; 1979 Dec 01; 135(7):876-86. PubMed ID: 507130 [Abstract] [Full Text] [Related]
37. Findings in female offspring of women exposed in utero to diethylstilbestrol. Kaufman RH, Adam E. Obstet Gynecol; 2002 Feb 15; 99(2):197-200. PubMed ID: 11814496 [Abstract] [Full Text] [Related]
38. Detection of chromosomal aberrations by fluorescence in situ hybridization in cervicovaginal biopsies from women exposed to diethylstilbestrol in utero. Hajek RA, King DW, Hernández-Valero MA, Kaufman RH, Liang JC, Chilton JA, Edwards CL, Wharton JT, Jones LA. Int J Gynecol Cancer; 2006 Feb 15; 16(1):318-24. PubMed ID: 16445652 [Abstract] [Full Text] [Related]
40. The development of cervical and vaginal adenosis as a result of diethylstilbestrol exposure in utero. Laronda MM, Unno K, Butler LM, Kurita T. Differentiation; 2012 Oct 15; 84(3):252-60. PubMed ID: 22682699 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]